TROXERUTIN-DARNITSA

The action of the drug is aimed at pain reduction, improvement of various pathological disorders associated with venous insufficiency

learn more

TROXERUTIN-DARNITSA

The action of the drug is aimed at pain reduction, improvement of various pathological disorders associated with venous insufficiency. It is indicated for the symptomatic treatment of: venous insufficiency and pre-varicose and varicose syndrome, superficial thrombophlebitis, phlebitis and post-phlebitis conditions; for the combined therapy of haemorrhoidal disease; swelling and pain in injuries and varicose veins; convulsive contractures of calf muscles.

More in instructions (Ukrainian version)
INN
Troxerutinum
Діюча речовина
Troxerutinum
Package
20 mg/g,30 g tube
Form of release
Gel
АТС class
C05C A04

TROXERUTIN-DARNITSA

learn more

  • 47 Millions of Packs of Creams, Ointments, Gels

    Traditions of generations and professional experience are those very foundations on the basis of which the Pharmaceutical Firm “Darnitsa” carries out its gradual development. Together with introduction of innovation technologies and state-of-the-art equipment, that has been ensuring the company’s flawless reputation in the Ukrainian market for 87 years. Today “Darnitsa” is the largest national manufacturer of medicinal products by volume. The product range includes nearly 25

See also

See also

Specialized publications intended for medical institutions and doctors Limitations in obtaining information